S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

11/12/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/Wade Moss, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Anila Lingamneni

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Haemonetics (NYSE:HAE)
Historical Stock Chart
From Nov 2024 to Dec 2024

Click Here for more Haemonetics Charts.

Haemonetics (NYSE:HAE)
Historical Stock Chart
From Dec 2023 to Dec 2024

Click Here for more Haemonetics Charts.

Haemonetics Corp News

Form 8-K - Current report
Tuesday 3 December 2024 (3 weeks ago) • Edgar (US Regulatory)

Haemonetics Announces Sale of Whole Blood Assets to GVS, S.p.A
Tuesday 3 December 2024 (3 weeks ago) • PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Thursday 14 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Tuesday 12 November 2024 (1 month ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Friday 8 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 7 November 2024 (1 month ago) • Edgar (US Regulatory)

Haemonetics 2nd Quarter Fiscal Year 2025 Earnings Release Available on Investor Relations Website
Thursday 7 November 2024 (1 month ago) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Tuesday 5 November 2024 (2 months ago) • Edgar (US Regulatory)

Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024
Thursday 3 October 2024 (3 months ago) • PR Newswire (US)

Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
Tuesday 24 September 2024 (3 months ago) • GlobeNewswire Inc.

More Haemonetics Corp News Articles

Clean Vision (QB)

SMC Entertainment (PK)

Lightwave Logic

Digital Brand Media and ... (PK)

Anavex Life Sciences

Asia Broadband (PK)

Elite Pharmaceuticals (QB)

North Bay Resources (PK)

Bioelectronics (PK)

Northwest Biotherapeutics (QB)

Fannie Mae (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions